Skip to main content
Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · IEX Real-Time Price · USD
2.295
-0.105 (-4.38%)
At close: Jul 19, 2024, 4:00 PM
2.290
-0.005 (-0.22%)
Pre-market: Jul 22, 2024, 7:36 AM EDT

Caribou Biosciences Revenue

Caribou Biosciences had revenue of $33.40M in the twelve months ending March 31, 2024, with 127.41% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $2.43M. In the year 2023, Caribou Biosciences had annual revenue of $34.48M with 148.91% growth.

Revenue (ttm)
$33.40M
Revenue Growth
+127.41%
P/S Ratio
6.21
Revenue / Employee
$211,418
Employees
158
Market Cap
207.28M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202334.48M20.63M148.91%
Dec 31, 202213.85M4.25M44.31%
Dec 31, 20219.60M-2.76M-22.35%
Dec 31, 202012.36M6.57M113.56%
Dec 31, 20195.79M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
The Joint 119.12M
Biodesix 54.85M
Genfit 42.42M
CVRx, Inc. 42.09M
bluebird bio 21.73M
Abeona Therapeutics 3.50M
Shattuck Labs 2.72M
Century Therapeutics 1.37M
Revenue Rankings

CRBU News

More News